A translational platform PBPK model for antibody disposition in the brain
Authors:
- 21 May 2019
- journal article
- research article
- Published by Springer Nature in Journal of Pharmacokinetics and Pharmacodynamics
- Vol. 46 (4) , 319-338
Abstract
In this manuscript, we have presented the development of a novel platform physiologically-based pharmacokinetic (PBPK) model to characterize brain disposition of mAbs in the mouse, rat, monkey and human. The model accounts for known anatomy and physiology of the brain, including the presence of distinct blood–brain barrier and blood–cerebrospinal fluid (CSF) barrier. CSF and interstitial fluid turnover, and FcRn mediated transport of mAbs are accounted for. The model was first used to characterize published and in-house pharmacokinetic (PK) data on the disposition of mAbs in rat brain, including the data on PK of mAb in different regions of brain determined using microdialysis. Majority of model parameters were fixed based on literature reported values, and only 3 parameters were estimated using rat data. The rat PBPK model was translated to mouse, monkey, and human, simply by changing the values of physiological parameters corresponding to each species. The translated PBPK models were validated by a priori predicting brain PK of mAbs in all three species, and comparing predicted exposures with observed data. The platform PBPK model was able to a priori predict all the validation PK profiles reasonably well (within threefold), without estimating any parameters. As such, the platform PBPK model presented here provides an unprecedented quantitative tool for prediction of mAb PK at the site-of-action in the brain, and preclinical-to-clinical translation of mAbs being developed against central nervous system (CNS) disorders. The proposed model can be further expanded to account for target engagement, disease pathophysiology, and novel mechanisms, to support discovery and development of novel CNS targeting mAbs.Keywords
Funding Information
- National Institute of General Medical Sciences (GM114179)
- National Institute of Allergy and Infectious Diseases (AI138195)
This publication has 87 references indexed in Scilit:
- Utility of CSF in translational neuroscienceJournal of Pharmacokinetics and Pharmacodynamics, 2013
- Physiologically Based Pharmacokinetic Modeling to Investigate Regional Brain Distribution Kinetics in RatsThe AAPS Journal, 2012
- Penetration of Drugs through the Blood-Cerebrospinal Fluid/Blood-Brain Barrier for Treatment of Central Nervous System InfectionsClinical Microbiology Reviews, 2010
- Physiologically based pharmacokinetic model for T84.66: A monoclonal anti-CEA antibodyJournal of Pharmaceutical Sciences, 2010
- Physiologic upper limits of pore size of different blood capillary types and another perspective on the dual pore theory of microvascular permeabilityJournal of Angiogenesis Research, 2010
- Investigation of the Influence of FcRn on the Distribution of IgG to the BrainThe AAPS Journal, 2009
- Multiplicity of cerebrospinal fluid functions: New challenges in health and diseaseFluids and Barriers of the CNS, 2008
- A Predictive Model of Therapeutic Monoclonal Antibody Dynamics and Regulation by the Neonatal Fc Receptor (FcRn)Annals of Biomedical Engineering, 2005
- Reduced cerebrospinal fluid production and intracranial pressure in mice lacking choroid plexus water channel Aquaporin‐1The FASEB Journal, 2004
- Global sensitivity indices for nonlinear mathematical models and their Monte Carlo estimatesMathematics and Computers in Simulation, 2001